BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Laborda TJ, Jensen MK, Kavan M, Deneau M. Treatment of primary sclerosing cholangitis in children. World J Hepatol 2019; 11(1): 19-36 [PMID: 30705716 DOI: 10.4254/wjh.v11.i1.19] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Mehta TI, Weissman S, Fung BM, Tabibian JH. Geoepidemiologic variation in outcomes of primary sclerosing cholangitis. World J Hepatol 2020; 12(4): 116-124 [PMID: 32685104 DOI: 10.4254/wjh.v12.i4.116] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
2 Seerat I, Khan EUD, Atique M, Aujla UI. Clinical spectrum of chronic liver disease with final outcome in children at a tertiary centre: A single - centre study. Pak J Med Sci 2021;37:680-3. [PMID: 34104147 DOI: 10.12669/pjms.37.3.3862] [Reference Citation Analysis]
3 Seerat I, Atique M, Khan EUD, Akram A, Iqbal A. Diagnosing Primary Sclerosing Cholangitis in Children. Cureus 2020;12:e8334. [PMID: 32617210 DOI: 10.7759/cureus.8334] [Reference Citation Analysis]
4 Aboughalia H, Kim HH, Dick AAS, Pacheco MC, Cilley RE, Iyer RS. Pediatric biliary disorders: Multimodality imaging evaluation with clinicopathologic correlation. Clin Imaging 2021;75:34-45. [PMID: 33493735 DOI: 10.1016/j.clinimag.2021.01.006] [Reference Citation Analysis]
5 Fischer RT, Day JC, Wasserkrug H, Faseler M, Kats A, Daniel JF, Slowik V, Andrews W, Hendrickson RJ. Complications of Cryptosporidium infection after pediatric liver transplantation: Diarrhea, rejection, and biliary disease. Pediatr Transplant 2020;24:e13807. [PMID: 32777150 DOI: 10.1111/petr.13807] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
6 Kemme S, Mack CL. Pediatric Autoimmune Liver Diseases: Autoimmune Hepatitis and Primary Sclerosing Cholangitis. Pediatr Clin North Am 2021;68:1293-307. [PMID: 34736590 DOI: 10.1016/j.pcl.2021.07.006] [Reference Citation Analysis]
7 Kamath BM, Stein P, Houwen RHJ, Verkade HJ. Potential of ileal bile acid transporter inhibition as a therapeutic target in Alagille syndrome and progressive familial intrahepatic cholestasis. Liver Int 2020;40:1812-22. [PMID: 32492754 DOI: 10.1111/liv.14553] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
8 Laborda TJ, Ricciuto A, Aumar M, Carman N, DiGuglielmo M, Draijer LG, Furuya KN, Gupta N, Koot BGP, Loomes KM, Lytvyak E, Martinez M, Miloh T, Montano-Loza AJ, Perito ER, Sathya P, Shah U, Shteyer E, Singh R, Taylor A, Valentino PL, Vitola B, Zerofsky M, Zizzo A, Deneau MR. Vedolizumab Therapy in Children With Primary Sclerosing Cholangitis: Data From the Pediatric Primary Sclerosing Cholangitis Consortium. J Pediatr Gastroenterol Nutr 2020;71:459-64. [PMID: 32740528 DOI: 10.1097/MPG.0000000000002855] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Wiecek S, Wojtyniak A, Pindur B, Machnikowska-Sokołowska M, Gruszczyńska K, Grzybowska-Chlebowczyk U. Analysis of the Clinical Course of Primary Sclerosing Cholangitis in Paediatric Population-Single Center Study. Medicina (Kaunas) 2021;57:663. [PMID: 34199130 DOI: 10.3390/medicina57070663] [Reference Citation Analysis]
10 Du W, Han W, Dong J. Long-term oral vancomycin for refractory inflammatory bowel diseases without Clostridium difficile infection: Lessons from primary sclerosing cholangitis. Med Hypotheses 2020;144:110211. [PMID: 33254520 DOI: 10.1016/j.mehy.2020.110211] [Reference Citation Analysis]
11 Jabandziev P, Kakisaka T, Bohosova J, Pinkasova T, Kunovsky L, Slaby O, Goel A. MicroRNAs in Colon Tissue of Pediatric Ulcerative Pancolitis Patients Allow Detection and Prognostic Stratification. J Clin Med 2021;10:1325. [PMID: 33806966 DOI: 10.3390/jcm10061325] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]